Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
PTPI | US
0.01
2.90%
Healthcare
Drug Manufacturers-Specialty & Generic
30/06/2024
04/10/2024
0.35
0.35
0.36
0.35
Petros Pharmaceuticals Inc. a pharmaceutical company focuses on men's health therapeutics in the United States and internationally. It operates through two segments Prescription Medications and Medical Devices. The company engages in the commercialization and development of Stendra an PDE-5 inhibitor prescription medication for the treatment of erectile dysfunction (ED). It also develops and commercializes H100 a novel and patented topical formulation candidate for the treatment of acute Peyronie's disease. The company offers men's health products including vacuum erection devices PreBoost VenoSeal penile injections and urinary tract infection tests for the treatment of erectile dysfunction. Petros Pharmaceuticals Inc. is based in New York New York.
View LessValue Stock (Price to Book < 3)
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
High Debt to Equity (> 0.75)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
64.6%1 month
50.6%3 months
59.4%6 months
76.5%-
-
0.42
0.83
0.30
-0.15
1.13
-
-10.13M
3.41M
3.41M
-
-160.46
-
-28.70
-63.77
2.54
2.88
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.06
Range1M
0.09
Range3M
0.19
Rel. volume
0.55
Price X volume
14.66K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Sonoma Pharmaceuticals Inc | SNOA | Drug Manufacturers-Specialty & Generic | 2.78 | 3.72M | -5.44% | n/a | 8.44% |
SHPH | SHPH | Drug Manufacturers-Specialty & Generic | 1.165 | 3.43M | -2.10% | n/a | 144.16% |
Avenue Therapeutics Inc | ATXI | Drug Manufacturers-Specialty & Generic | 2.075 | 2.97M | -14.26% | 0.07 | 0.00% |
Akanda Corp. Common Shares | AKAN | Drug Manufacturers-Specialty & Generic | 1.07 | 2.78M | 0.94% | n/a | -104.44% |
China SXT Pharmaceuticals Inc | SXTC | Drug Manufacturers-Specialty & Generic | 0.719 | 2.50M | -9.67% | n/a | 19.00% |
Bio-Path Holdings Inc | BPTH | Drug Manufacturers-Specialty & Generic | 0.871 | 2.22M | -1.28% | n/a | 4.26% |
PRFX | PRFX | Drug Manufacturers-Specialty & Generic | 0.6413 | 791.65K | 4.68% | n/a | -2.89% |
Sunshine Biopharma Inc. Warrant | SBFMW | Drug Manufacturers-Specialty & Generic | 0.103 | 0 | -0.96% | n/a | 2.46% |
Biofrontera Inc. Warrants | BFRIW | Drug Manufacturers-Specialty & Generic | 0.02 | 0 | n/a | 13.20% | |
Alvotech Warrant | ALVOW | Drug Manufacturers-Specialty & Generic | 2.98 | 0 | n/a | -196.14% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.3899 | 3.55M | -0.01% | n/a | 9.62% |
Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 0.4859 | 2.44M | -9.19% | n/a | 0.00% |
Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.01 | 913.02K | -1.96% | n/a | -37.05% |
Blackstone/GSO Senior Floating Rate Term Fund | BSL | Textile Manufacturing | 14.17 | 0 | 0.78% | n/a |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -0.15 | 17.21 | Cheaper |
Ent. to Revenue | 1.13 | 334.38 | Cheaper |
PE Ratio | - | 26.92 | - |
Price to Book | 0.42 | 12.15 | Cheaper |
Dividend Yield | - | 2.77 | - |
Std. Deviation (3M) | 59.42 | 68.34 | Par |
Debt to Equity | 0.83 | -1.00 | Expensive |
Debt to Assets | 0.30 | 0.48 | Cheaper |
Market Cap | 3.41M | 5.31B | Emerging |